These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24068654)

  • 1. The effect of St John's wort on the pharmacokinetics of docetaxel.
    Goey AK; Meijerman I; Rosing H; Marchetti S; Mergui-Roelvink M; Keessen M; Burgers JA; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2014 Jan; 53(1):103-10. PubMed ID: 24068654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Clin Pharmacokinet; 2019 Jul; 58(7):911-926. PubMed ID: 30675694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.
    Goey AK; Meijerman I; Rosing H; Burgers JA; Mergui-Roelvink M; Keessen M; Marchetti S; Beijnen JH; Schellens JH
    Br J Clin Pharmacol; 2013 Sep; 76(3):467-74. PubMed ID: 23701184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
    Mai I; Bauer S; Perloff ES; Johne A; Uehleke B; Frank B; Budde K; Roots I
    Clin Pharmacol Ther; 2004 Oct; 76(4):330-40. PubMed ID: 15470332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.
    Mueller SC; Majcher-Peszynska J; Uehleke B; Klammt S; Mundkowski RG; Miekisch W; Sievers H; Bauer S; Frank B; Kundt G; Drewelow B
    Eur J Clin Pharmacol; 2006 Jan; 62(1):29-36. PubMed ID: 16341856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction between St John's wort and zolpidem in healthy subjects.
    Hojo Y; Echizenya M; Ohkubo T; Shimizu T
    J Clin Pharm Ther; 2011 Dec; 36(6):711-5. PubMed ID: 21058968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St. John's Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content.
    Schäfer AM; Rysz MA; Schädeli J; Hübscher M; Khosravi H; Fehr M; Seibert I; Potterat O; Smieško M; Meyer Zu Schwabedissen HE
    Mol Pharmacol; 2023 Dec; 105(1):14-22. PubMed ID: 37863663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot study.
    Donovan JL; DeVane CL; Lewis JG; Wang JS; Ruan Y; Chavin KD; Markowitz JS
    Phytother Res; 2005 Oct; 19(10):901-6. PubMed ID: 16261523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.
    Mueller SC; Majcher-Peszynska J; Mundkowski RG; Uehleke B; Klammt S; Sievers H; Lehnfeld R; Frank B; Thurow K; Kundt G; Drewelow B
    Eur J Clin Pharmacol; 2009 Jan; 65(1):81-7. PubMed ID: 18762932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.
    Whitten DL; Myers SP; Hawrelak JA; Wohlmuth H
    Br J Clin Pharmacol; 2006 Nov; 62(5):512-26. PubMed ID: 17010103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.
    Xu H; Williams KM; Liauw WS; Murray M; Day RO; McLachlan AJ
    Br J Pharmacol; 2008 Apr; 153(7):1579-86. PubMed ID: 18204476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.
    Gödtel-Armbrust U; Metzger A; Kroll U; Kelber O; Wojnowski L
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):377-82. PubMed ID: 17593354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.